DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Talsaclidine
Talsaclidine
WITHOUTUS010307409B2 (12 ) United States Patent ( 10 ) Patent No
Wo 2007/128674 A2
(Tert- Butoxycarbonyl)Amino](3 361442- 3
Alzheimer's Disease Clinical Trials
Structure-Based Discovery of Prescription Drugs That Interact with the Norepinephrine Transporter, NET
30Th Annual Meeting of Society for Neuroscience. New Drugs Affecting the Central Nervous System New Orleans, Louisiana, USA November 4–9, 2000
(12) Patent Application Publication (10) Pub. No.: US 2007/0099986 A1 Ishiichi Et Al
Alzheimer Syllabus
The Action of Xanomeline on Human Muscarinic Receptors Expressed in Chinese Hamster Ovary Cells
United States Patent (10) Patent No.: US 8,003,632 B2 Tracey Et Al
Drugs Used in Alzheimer Disease
Lessons Learned
Fig. 2 ACADIA
Stembook 2018.Pdf
Clinical Trials and Late-Stage Drug Development in Alzheimer's Disease: an Appraisal from 1984 to 2014
Customs Tariff - Schedule
PIG&I* the USA. ALZHEIMER's DISEASE: CURRENT AND
(12) Patent Application Publication (10) Pub. No.: US 2017/0095465 A1 Elenko Et Al
Top View
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Pharmaabkommen A1 E
(12) Patent Application Publication (10) Pub. No.: US 2014/0349976 A1 HACKSELL Et Al
Pharmacological Investigations on Muscarinic and P2 Receptor Subtypes
Curriculum Vitae
Clinical Research Protocol
Muscarinic Acetylcholine Receptor
Customs Tariff - Schedule Xxi - 1
(12) United States Patent (10) Patent No.: US 8,865,641 B2 Pavlov Et Al
Neurogenesis Via Modulation of the Muscarinic Receptors
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Customs Tariff - Schedule
Evaluation of 11C-LSN3172176 As a Novel PET Tracer for Imaging M1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Structure-Based Discovery of Prescription Drugs That Interact with the Norepinephrine Transporter, NET
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) Patent Application Publication (10) Pub. No.: US 2011/0020423 A1 Elenko Et Al
Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: a Concept to Treat Alzheimer’S Disease
D3.3 Update of Potential Data Sources with RWE Data in Europe 18 Oct
Schedule Clxxiii - European Union
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri